Continuum Advisory’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$546K Buy
+12,796
New +$695K 0.04% 279
2025
Q2
Sell
-776
Closed -$78.3K 561
2025
Q1
$78.3K Sell
776
-137
-15% -$13.8K 0.01% 565
2024
Q4
$81.5K Buy
913
+21
+2% +$1.85K 0.01% 563
2024
Q3
$78.1K Buy
892
+18
+2% +$1.42K 0.01% 569
2024
Q2
$67.3K Buy
874
+268
+44% +$19.6K 0.01% 562
2024
Q1
$44.9K Buy
+606
New +$39K 0.01% 619

Other funds holding BSX

Continuum Advisory's BSX Position: Q2 2026 in Review

Continuum Advisory opened a new position in Boston Scientific (BSX) in Q2 2026: 12,796 shares worth $546K. The stake represents 0.04% of the portfolio and ranks #279 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in BSX as recently as Q1 2025.

Continuum Advisory first reported a position in BSX in Q1 2024 and has held it in 6 quarters since. 1,480 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Continuum Advisory held 12,796 shares of Boston Scientific worth $546K as of Q2 2026.
  • Boston Scientific was a new Continuum Advisory position in Q2 2026.
  • Boston Scientific made up 0.04% of Continuum Advisory's portfolio in Q2 2026, its #279 holding.
  • Continuum Advisory first reported a position in Boston Scientific in Q1 2024 and has held it in 6 quarters since.
  • 1,480 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.